Libya vs Slovenia: Cause of death, by non-communicable diseases, ages 5-14, female
Libya
50.9%
in 2021
Slovenia
52.0%
in 2021
Libya rank
60th
Slovenia rank
57th
Cause of death, by non-communicable diseases, ages 5-14, female over time
- Libya
- Slovenia
How they compare
Slovenia currently reports 52.0% against 50.9% in Libya, a difference of 1.1%.
Across all 6 years both countries report, Slovenia has been ahead every year.
Libya ranks 60th and Slovenia ranks 57th of 184 countries.
Slovenia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Libya | Slovenia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 50.4% | 53.4% | 3.0% | Slovenia |
| 2010s | 30.6% | 70.2% | 39.6% | Slovenia |
| 2020s | 41.2% | 51.8% | 10.6% | Slovenia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, female, Libya or Slovenia?
- Slovenia, at 52.0% against 50.9% in Libya as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14, female between Libya and Slovenia?
- 1.1%, with Slovenia ahead.
- How many years of comparable data are there for Libya and Slovenia?
- 6 years are reported by both, from 2000 to 2021.
- How do Libya and Slovenia rank globally for cause of death, by non-communicable diseases, ages 5-14, female?
- Libya ranks 60th and Slovenia ranks 57th of 184 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14, female (% of total female deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 5-14 due to non-communicable diseases divided by number of all female deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.